Barinthus Biotherapeutics plc (BRNS)
NASDAQ: BRNS · Real-Time Price · USD
0.6250
+0.0450 (7.76%)
Feb 20, 2026, 4:00 PM EST - Market closed
Barinthus Biotherapeutics Market Cap
Barinthus Biotherapeutics has a market cap or net worth of $25.52 million as of February 20, 2026. Its market cap has decreased by -37.19% in one year.
Market Cap
25.52M
Enterprise Value
-37.18M
1-Year Change
-37.19%
Ranking
Category
Stock Price
$0.63
Market Cap Chart
Since the IPO on April 30, 2021, Barinthus Biotherapeutics's market cap has decreased from $579.09M to $25.52M, a decrease of -95.59%. That is a compound annual growth rate of -47.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 25.52M | -10.73% |
| Dec 31, 2025 | 28.59M | -41.18% |
| Dec 31, 2024 | 48.60M | -65.85% |
| Dec 29, 2023 | 142.31M | 62.36% |
| Dec 30, 2022 | 87.65M | -77.38% |
| Dec 31, 2021 | 387.51M | -33.08% |
| Apr 30, 2021 | 579.09M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Evaxion | 27.44M |
| Passage Bio | 27.37M |
| Rallybio | 26.72M |
| Lixte Biotechnology Holdings | 26.49M |
| Cue Biopharma | 25.98M |
| Boundless Bio | 25.97M |
| Skye Bioscience | 25.05M |
| IGC Pharma | 24.93M |